HTFL
Heartflow, Inc.Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-05-14 |
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Total revenue of $52.6 million, a 41% |
| 2026-04-23 |
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026
SAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the first quarter of 2026 after market close on Thursday, May 14, 2026. |
| 2026-04-13 |
Heartflow Files Patent Infringement Lawsuit Against Cleerly
Heartflow asserts that Cleerly infringed foundational patented technology central to the Heartflow Platform MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it |
| 2026-03-18 |
Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results
MOUNTAIN VIEW, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the fourth quarter and full year ended December 31, 2025. |
| 2026-03-16 |
Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning
Three presentations at ACC reinforce Heartflow’s AI-powered technology predicts MACE, drives superior lipid outcomes and results in cost-effective care First patient enrolled in p ioneering N AVIGATE - PCI Registry assessing impact of Heartflow PCI Navigator on clinical strategy, efficiency and |
| 2026-02-18 |
Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference
MOUNTAIN VIEW, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Morgan Stanley Technology, Media & |
| 2026-02-13 |
Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
MOUNTAIN VIEW, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Wednesday, March |
| 2026-02-12 |
Heartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely Measuring Heart Disease Risk in Former Professional Athletes
NBA legend Muggsy Bogues joins effort to detect and manage coronary artery disease in retired players using AI-powered Heartflow Analysis MOUNTAIN VIEW, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease |
| 2026-01-06 |
Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.
Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque Analysis MOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow |
| 2026-01-05 |
Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference
MOUNTAIN VIEW, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today announced that members of management will present at the upcoming 44 th Annual J.P. |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-05-14 | Heartflow, Inc. First Quarter 2026 Earnings Call | Earnings call |
| 2026-03-18 | Heartflow, Inc. Fourth Quarter 2025 Earnings Call | Earnings call |
| 2026-03-03 | Morgan Stanley Technology, Media & Telecom Conference | Conference |
| 2026-01-13 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-12-03 | Piper Sandler 37th Annual Healthcare Conference | Conference |
| 2025-11-12 | Heartflow, Inc. Third Quarter 2025 Earnings Call | Earnings call |
| 2025-09-10 | Morgan Stanley 23rd Annual Global Healthcare Conference | Conference |
Source: https://ir.heartflow.com/